Italy: Advocates seek recognition for alopecia and vitiligo

In Italy, medical experts and patient associations are calling for the National Health Service to officially recognize alopecia areata and vitiligo. These autoimmune conditions affect over 270,000 Italians, with significant psychological impacts including high rates of anxiety and social isolation. Advocates, such as Claudia Cassia of AIPAF, emphasize that official recognition is crucial for patients to access proper care and disability exemptions.

The European Commission has recently approved upadacitinib, a JAK inhibitor that offers new therapeutic prospects. Clinical trials have shown it can achieve complete hair regrowth in severe alopecia areata and reduce skin pigment loss in non-segmental vitiligo.

On a regional level, Umbria has confirmed an 80,000 euro fund for 2026 to support oncology patients. This measure provides up to 300 euros per person for the purchase of wigs to assist with the psychological well-being of those experiencing hair loss due to chemotherapy. The regional government is also evaluating the possibility of extending such support to other forms of alopecia.